MX2010005816A - Epítopos de péptido de stat3. - Google Patents

Epítopos de péptido de stat3.

Info

Publication number
MX2010005816A
MX2010005816A MX2010005816A MX2010005816A MX2010005816A MX 2010005816 A MX2010005816 A MX 2010005816A MX 2010005816 A MX2010005816 A MX 2010005816A MX 2010005816 A MX2010005816 A MX 2010005816A MX 2010005816 A MX2010005816 A MX 2010005816A
Authority
MX
Mexico
Prior art keywords
peptides
stat3
epitope peptides
amino acid
provides
Prior art date
Application number
MX2010005816A
Other languages
English (en)
Inventor
Takuya Tsunoda
Ryuji Osawa
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of MX2010005816A publication Critical patent/MX2010005816A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001152—Transcription factors, e.g. SOX or c-MYC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity

Abstract

La presente invención proporciona péptidos que contienen la secuencia de aminoácidos de SEQ ID NO: 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 19, 20, 21, 22, 26, 27, 29, 30, 59, 61, 63, 64, 65, 66, 67, 68, 69, 70, 72, 73, 74, 75, 77, 83, 94, 96, 97, 98 o103, y péptidos que contienen una de las secuencias de aminoácido mencionadas anteriormente con sustitución o adición de uno, dos, o varios aminoácidos, y que tienen inducibilidad de células T citotóxicas, y también proporcionan fármacos que contienen estos péptidos. Los péptidos de esta invención se pueden usar como vacunas.
MX2010005816A 2007-11-28 2008-11-27 Epítopos de péptido de stat3. MX2010005816A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99087707P 2007-11-28 2007-11-28
PCT/JP2008/003497 WO2009069302A1 (en) 2007-11-28 2008-11-27 Stat3 epitope peptides

Publications (1)

Publication Number Publication Date
MX2010005816A true MX2010005816A (es) 2010-08-04

Family

ID=40678214

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005816A MX2010005816A (es) 2007-11-28 2008-11-27 Epítopos de péptido de stat3.

Country Status (12)

Country Link
US (1) US20110052614A1 (es)
EP (1) EP2247725A4 (es)
JP (1) JP2011504875A (es)
KR (1) KR20100101609A (es)
CN (1) CN101952429A (es)
AU (1) AU2008330996A1 (es)
CA (1) CA2706835A1 (es)
IL (1) IL206013A0 (es)
MX (1) MX2010005816A (es)
RU (1) RU2010126154A (es)
TW (1) TW200932260A (es)
WO (1) WO2009069302A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201136604A (en) 2009-12-14 2011-11-01 Oncotherapy Science Inc TMEM22 peptides and vaccines including the same
MX2012011668A (es) * 2010-04-09 2012-12-17 Oncotherapy Science Inc Peptidos cdca5 y vacunas que incluyen los mismos.
CN103145801B (zh) * 2011-05-26 2014-03-26 郑州大学 Mta1来源的抗肿瘤ctl表位肽及其应用
RU2015126849A (ru) * 2012-12-04 2017-01-12 Онкотерапи Сайенс, Инк. Пептиды sema5в и вакцины, содержащие эти пептиды
TW201636358A (zh) * 2014-12-09 2016-10-16 腫瘤療法 科學股份有限公司 對於ｔｈ１細胞之ｇｐｃ３抗原決定位胜肽及含此之疫苗

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07324096A (ja) * 1994-04-04 1995-12-12 Chuzo Kishimoto 転写調節物質ａｐｒｆ
US7098192B2 (en) * 1999-04-08 2006-08-29 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of STAT3 expression
US6159694A (en) * 1999-04-08 2000-12-12 Isis Pharmaceuticals Inc. Antisense modulation of stat3 expression
WO2003050140A1 (fr) * 2001-12-10 2003-06-19 Kyogo Itoh Antigenes tumoraux
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
JP4406607B2 (ja) * 2002-08-26 2010-02-03 オンコセラピー・サイエンス株式会社 ペプチド及びこれを含む医薬
EP2014678B1 (en) * 2002-09-12 2011-11-02 Oncotherapy Science, Inc. KDR peptides and vaccines comprising the same
JP4547197B2 (ja) * 2004-06-30 2010-09-22 公正 安元 癌特異的腫瘍抗原
EP1642905B1 (en) * 2004-10-02 2009-01-21 Immatics Biotechnologies GmbH Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
NZ567266A (en) * 2005-10-13 2010-09-30 Orchid Res Lab Ltd Carbazole derivatives as pSTAT3/IL-6 inhibitors (carvedilol)
WO2007060715A1 (ja) * 2005-11-22 2007-05-31 The University Of Tokyo インターロイキン－６（ｉｌ－６）シグナル伝達阻害剤スクリーニング方法
WO2007066423A1 (ja) * 2005-12-08 2007-06-14 Dainippon Sumitomo Pharma Co., Ltd. Ａｍａｃｒ由来の腫瘍抗原ペプチド
JP2009091249A (ja) * 2006-01-23 2009-04-30 Univ Kurume Ｃ型肝炎ウイルス２ａ由来ＨＬＡ−Ａ２拘束性抗原ペプチド
WO2007101227A2 (en) * 2006-02-27 2007-09-07 Arizona Board Of Regents For And On Behalf Of Arizona State University Identification and use of novopeptides for the treatment of cancer

Also Published As

Publication number Publication date
RU2010126154A (ru) 2012-01-10
WO2009069302A1 (en) 2009-06-04
EP2247725A4 (en) 2011-05-11
KR20100101609A (ko) 2010-09-17
IL206013A0 (en) 2010-11-30
AU2008330996A1 (en) 2009-06-04
EP2247725A1 (en) 2010-11-10
CN101952429A (zh) 2011-01-19
US20110052614A1 (en) 2011-03-03
JP2011504875A (ja) 2011-02-17
CA2706835A1 (en) 2009-06-04
TW200932260A (en) 2009-08-01

Similar Documents

Publication Publication Date Title
EP2573109A3 (en) Peptide vaccines comprising Seq Id 101, 80 or 100 for cancers expressing tumor-associated antigens
MX2009004147A (es) Vacunas de peptido para canceres que expresan polipeptidos mphosph1 o depdc1.
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
EP2267021A3 (en) KDR peptides and vaccines comprising the same
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
MX2009007261A (es) Vacuna de peptido foxp3.
NZ609216A (en) Anticancer fusion protein
WO2016130628A8 (en) Griffithsin mutants
SG10201407944TA (en) Imp-3 oligopeptides and vaccines including the same
MX2011007963A (es) Peptidos neil3 y vacunas que incluyen los mismos.
MX2010005816A (es) Epítopos de péptido de stat3.
PT2289533E (pt) Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos
WO2011135222A3 (fr) Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles
NZ592461A (en) Rab6kifl/kif20a epitope peptide and vaccines containing the same
EP3026057A3 (en) Compositions for prevention and treatment of neurodegenerative diseases
EP3208334A3 (en) Cdc45l peptides and vaccines including the same
MX2011008917A (es) Peptidos vangl1 y vacunas que incluyen los mismos.
EP4047009A3 (en) Wdrpuh epitope peptides and vaccines containing the same
GB201018125D0 (en) Peptide
NZ603379A (en) Ect2 peptides and vaccines including the same
WO2009083968A8 (en) Novel protein
WO2009149094A3 (en) Cytotoxic t cell defined egfr peptide and an optimized derivative peptide
GB201019467D0 (en) Therapeutic agent

Legal Events

Date Code Title Description
FA Abandonment or withdrawal